Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy

Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy

Type 2 diabetes mellitus (T2DM) is a global health concern, with diabetic neuropathy (DN) being a prevalent complication. Current DN treatments focus on blood glucose control and pain management, which show limited efficacy. This study explored the effects of autologous dendritic cell (DC) administr...

Full description

Saved in:
Bibliographic Details
Main Authors: Erwin Setiawan, Chrismis Novalinda Ginting, Jonny Jonny, Bhimo Aji Hernowo, Terawan Agus Putranto
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Current Issues in Molecular Biology
Subjects:
diabetic neuropathy
autologous dendritic cells
Toronto Clinical Neuropathy Score
Transforming Growth Factor-β
Vascular Cell Adhesion Molecule-1
Online Access:https://www.mdpi.com/1467-3045/46/12/861
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1467-3045/46/12/861

Similar Items